IAIM
REGN icon

International Assets Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

International Assets Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
1,001
+120
+14% +$81.7K 0.04% 400
2026
Q1 		$685K Buy
881
+8
+0.9% +$6.13K 0.05% 347
2025
Q4 		$674K Buy
873
+145
+20% +$98.5K 0.05% 359
2025
Q3 		$389K Buy
728
+4
+0.6% +$2.26K 0.03% 525
2025
Q2 		$380K Buy
724
+167
+30% +$93.2K 0.03% 531
2025
Q1 		$353K Sell
557
-9
-2% -$6.19K 0.03% 518
2024
Q4 		$405K Sell
566
-880,373
-100% -$739M 0.03% 481
2024
Q3 		$838 Buy
880,939
+879,916
+86,013% +$979M ﹤0.01% 1192
2024
Q2 		$1.08M Buy
1,023
+287
+39% +$278K 0.1% 187
2024
Q1 		$713K Buy
736
+63
+9% +$59.9K 0.07% 277
2023
Q4 		$591K Sell
673
-102
-13% -$84K 0.08% 293
2023
Q3 		$645K Sell
775
-29
-4% -$22.8K 0.09% 222
2023
Q2 		$578K Buy
804
+58
+8% +$44.7K 0.08% 245
2023
Q1 		$613K Sell
746
-15,019
-95% -$11.3M 0.09% 227
2022
Q4 		$564K Buy
15,765
+15,459
+5,052% +$11.4M 0.06% 324
2022
Q3 		$211K Buy
+306
New +$193K 0.05% 364
2021
Q2 		– Sell
-436
Closed -$208K – 1571
2021
Q1 		$208K Buy
436
+231
+113% +$112K 0.02% 504
2020
Q4 		$99K Buy
+205
New +$111K 0.02% 598

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

International Assets Investment Management's REGN Position: Q2 2026 in Review

International Assets Investment Management increased its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, buying an estimated $81.7K and bringing the position to 1,001 shares worth $625K. The position accounts for 0.04% of the portfolio, ranked #400.

International Assets Investment Management first reported a position in REGN in Q4 2020 and has held it in 18 quarters since. The position peaked at $1.08M in Q2 2024. 955 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • International Assets Investment Management held 1,001 shares of Regeneron Pharmaceuticals worth $625K as of Q2 2026.
  • International Assets Investment Management bought 120 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $81.7K.
  • Regeneron Pharmaceuticals made up 0.04% of International Assets Investment Management's portfolio in Q2 2026, its #400 holding.
  • International Assets Investment Management first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 18 quarters since.
  • International Assets Investment Management's Regeneron Pharmaceuticals position peaked at $1.08M in Q2 2024.
  • 955 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.